Nivolumab Effective for Gastric and Lung Cancers but Not for Multiple Myeloma in a Multiple Primary Cancer Patient
| Autor: | Tomoyuki Tsuzuki, Yoshimasa Tanikawa, Tsukasa Yasuda, Junji Hiraga, Michihiko Narita |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Oncology
medicine.medical_specialty Lung business.industry Standard treatment Cancer Case Report General Medicine medicine.disease Primary cancer Metastasis medicine.anatomical_structure Internal medicine Medicine Diseases of the blood and blood-forming organs Nivolumab RC633-647.5 business Lung cancer Multiple myeloma |
| Zdroj: | Case Reports in Hematology, Vol 2021 (2021) Case Reports in Hematology |
| ISSN: | 2090-6579 2090-6560 |
| Popis: | The case of a 76-year-old man with multiple primary cancers that were treated with nivolumab is presented. Six years earlier, he was diagnosed with multiple myeloma (MM) and was treated with several chemotherapies. He was also diagnosed with gastric cancer with liver metastasis and primary lung cancer by upper gastrointestinal endoscopy and computed tomography (CT). Nivolumab treatment was given as third-line therapy, and it was effective for gastric and lung cancers. But MM worsened, and the patient died. There is no standard treatment for multiple primary cancers, and the development of effective treatments for multiple primary cancers is important. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text